STRUCTURE FUNCTION RELATIONSHIPS OF COBROTOXIN FROM NAJA NAJA ATRA

References

• Ackermann E. J., Ang E. T. H., Kanter J. R., Tsinelny I., Taylor P. Identification of pair wise interactions in the alpha-neurotoxin nicotinic acetylcholine receptor complex through double mutant cycles. J. Biol. Chem. 1998; 273: 10958–10964
   PubMedGoogle Scholar
• Ackermann E. J., Taylor P. Non-identity of the alpha-neurotoxin binding sites on the nicotinic acetylcholine receptor revealed by modification in alpha-neurotoxin and receptor structure. Biochemistry 1997; 36: 12836–12844
   PubMedGoogle Scholar
• Antil-Delbeke S., Servent D., Menez A. Variability among the sites by which curaremimetic toxins bind to Torpedo acetylcholine receptor, as revealed by identification of the functional residues of alpha-cobratoxin. J. Biol. Chem. 1999; 274: 34851–34858
   PubMedGoogle Scholar
• Antil-Delbeke S., Gaillard C., Tamiya T., Corringer P. J., Changeux J. P., Servent D., Menez A. Molecular determinants by which a long chain toxin from snake venom interacts with the neuronal alpha 7-nicotinic acetylcholine receptor. J. Biol. Chem. 2000; 275: 29594–29601
   PubMedGoogle Scholar
• Arias H. R. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors. Neurochem. Int. 2000; 36: 595–645
   PubMed Web of Science ®Google Scholar
• Basus V. T., Song G., Hawort E. NMR solution structure of an α-bungarotoxin/nicotinic receptor peptide complex. Biochemistry 1993; 32: 12290–12298
   PubMed Web of Science ®Google Scholar
• Bhaskaran R., Huang C. C., Chang D. K., Yu C. Cardiotoxin III from Taiwan cobra (Naja naja atra)—determination of structure in solution and comparison with short neurotoxins. J. Mol. Biol. 1994a; 235: 1291–1301
   PubMed Web of Science ®Google Scholar
• Bhaskaran R., Huang C.-C., Tsai Y.-C., Jayaraman G., Chang D.-K., Yu. C. Cardiotoxin II from Taiwan cobra venom, Naja naja atra-structure in solution and comparision among homologous cardiotoxins. J. Biol. Chem. 1994b; 269: 23500–23508
   PubMed Web of Science ®Google Scholar
• Bhaskaran R., Yu C., Yang C. C. Solution structure and functional implications of toxins from Taiwan cobra venom, Naja naja atra. J. Protein Chem. 1994c; 13: 503–504
   Google Scholar
• Bourne Y., Talley T. T., Hansen S. B., Taylor P., Marchot P. Crystal structure of Cbtx-AChBP complex reveals essential interactions between snake-neurotoxins and nicotinic receptors. EMBO 2005; 24: 1512–1522
   PubMed Web of Science ®Google Scholar
• Brejc K., Van Dijk W. J., Klaassen R. V., Schuurmans M., Smit A. B., Sixma T. K. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 2001; 411: 269–276
   PubMed Web of Science ®Google Scholar
• Brown L. R., Wuthrich K. Nuclear magenetic resonance solution structure of the α-neurotoxin from black mamba (Dendroaspis polylepis polylepis). J. Mol. Biol. 1992; 227: 1118–1135
   PubMed Web of Science ®Google Scholar
• Chang C. C., Yang C. C., Nakai K., Hayashi K. Studies on the status of free amino and carboxyl groups in cobrotoxin. Biochim. BioPhys. Acta 1971; 251: 334–344
   PubMed Web of Science ®Google Scholar
• Chang L. S., Chou Y. C., Lin S. R., Wu B. N., Lin J., Hong E., Sun Y. J., Hsiao C. D. A novel neurotoxin, cobrotoxin b, from Naja naja atra (Taiwan cobra) venom: purification, characterization, and gene organization. J. Biochem. (Tokyo) 1997; 122: 1252–1259
   PubMedGoogle Scholar
• Chang L. S., Lin R., Chen K. C., Chang C. C. Enrichment of antibodies against the C-terminus of Taiwan cobra cobrotoxin using dimeric glutaraldehyde-modified toxin as an immunogen. Toxicon 2003; 41: 81–186
   PubMedGoogle Scholar
• Chang L. S., Lin R., Yang C. C. Refolding of Taiwan cobra neurotoxin: intramolecular cross-link affects its refolding reaction. Arch. Biochem. Biophys. 2001; 387: 289–296
   PubMedGoogle Scholar
• Chang L. S., Lin S. R., Chang C. C. Unfolding/folding studies on cobrotoxin from Taiwan cobra venom: pH and GSH/GSSG govern disulfide isomerization at the C-terminus. Arch. Biochem. Biophys. 1998; 354: 1–8
   PubMed Web of Science ®Google Scholar
• Chang L. S., Lin S. R., Chang C. C., Yang C. C. Disulfide isomerization within the C-Terminus of Cobrotoxin decelerates by thiol compounds and trinitrophenylation, but accelerates by modification of carboxyl groups. Arch. Biochem. Biophys. 1998; 358: 164–170
   PubMedGoogle Scholar
• Changeux J. P., Edelstein S. J. Allosteric receptors after 30 years. Neuron 1998; 21: 959–980
   PubMedGoogle Scholar
• Changeux J. P., Kasai M., Lee C. Y. Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc. Natl. Acad. Sci. USA 1970; 67: 1241–1247
   PubMed Web of Science ®Google Scholar
• Cheng Y., Meng Q. X., Wang W. Y., Wang J. F. Structure–function relationship of three neurotoxins from the venom of Naja kaouthia: a comparison between the NMR-derived structure of NT2 with its homologues, NT1 and NT3. Biochim. Biophys. Acta 2002; 1594: 353–363
   PubMedGoogle Scholar
• Chicheportiche R., Vincent J. P., Kopeyan C., Schweitz H., Lazdunski M. Structure–function relationships in the binding of snake neurotoxins to the Torpedo membrane receptors. Biochemistry 1975; 14: 2081–2091
   PubMed Web of Science ®Google Scholar
• Corfield P., Lee T. J., Low B. W. The crystal structure of erabutoxin a at 2.0 Å resolution. J. Biol. Chem 1989; 264: 9239–9242
   PubMed Web of Science ®Google Scholar
• Corringer P. J., Le Novere N., Changeux J. P. Nicotinic receptor at the amino acid level. Annu. Rev. Pharmacol. Toxicol. 2000; 40: 431–458
   Google Scholar
• Dufton M. J., Hider R. C. Conformational properties of the neurotoxins and cytotoxins isolated from Elapid snake venoms. CRC Cric. Rev. Biochem. 1983; 14: 113–171
   PubMed Web of Science ®Google Scholar
• Fruchart-Gaillard C., Gilquin B., Antil-Delbeke S., Le-Novere N., Tamiya T., Corringer P. J., Changeux J. P., Menez A., Servent D. Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor. Proc. Natl. Acad. Sci. USA 2002; 99: 3216–3221
   PubMedGoogle Scholar
• Golovanov A. P., Lomize A. L., Arseniev A. S., Utkin Y. N., Tsetlin V. I. 1H NMR study of the spatial structure of neurotoxin II from Naja naja oxiana. J. Biol. Chem. 1993; 213: 1213–1223
   Google Scholar
• Grutter T., Changeux J. P. Nicotinic receptors in wonderland. Trends Biochem. Sci. 2001; 26: 459–463
   PubMed Web of Science ®Google Scholar
• Hajduk P. J., Meadows R. P., Fesik S. W. NMR-based screening in drug discovery. Q. Rev. Biophys. 1999; 32: 211–240
   PubMed Web of Science ®Google Scholar
• Harvey A. L. Cardiotoxins from cobra venom: Possible mechanism of action. J. Toxicol. Toxin Rev. 1985; 40: 41–69
   Google Scholar
• Harvey A. L. Toxins leading to medicines. Perspectives in Molecular Toxicology, A. Menez. John Willey & Sons, ChichesterEngland 2002a; 377–382
   Google Scholar
• Harvey A. L. Toxins ‘R’ Us: more pharmacological tools from nature's superstore. Trends Pharmacol. Sci. 2002b; 23: 201–203
   PubMedGoogle Scholar
• Harvey A. L., Bradley K. N., Cochran S. A. What can toxins tell us for drug discovery?. Toxicon 1998; 36: 1635–1640
   PubMed Web of Science ®Google Scholar
• Hatanaka H. M., Oka M., Khoda D., Tate S., Suda A., Tamiya N., Inagaki F. Tertiary structure of erabutoxin-B in aqueous solution as elucidated by 2-dimentional nuclear-magnetic-resonance. J. Mol. Biol. 1994; 240: 155–166
   PubMedGoogle Scholar
• Heeschen C., Weis M., Aicher A., Dimmeler S., Cooke J. P. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J. Clin. Invest. 2002; 110: 527–536
   PubMed Web of Science ®Google Scholar
• Hsieh H.-C., Kumar T. K. S., Yu C. Cloning, overexpression and characterization of cobrotoxin. Biochim. Biophys. Acta 2004; 320: 1374–1381
   Google Scholar
• Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev. Neurosci. 2002; 3: 102–114
   Google Scholar
• Karlsson E., Pongsawasdi P. Purification of two phospholipase A isoenzymes with anticoagulant activity from the venom of the cobra. Naja naja siamensis, Toxicon. 1980; 18(4): 409–419
   Google Scholar
• Kumar T. K. S., Srisailam S., Vethanayagam R. R., Yu C. Understanding the structure and functional relationship of snake venom cardiotoxins. Perspectives in Molecular Toxicology, A. Menez. John Willey & Sons, ChichesterEngland 2002; 315–325
   Google Scholar
• Lee C. Y., Chang C. C., Chen Y. M. Reversibility of neuromuscular blockade by neurotoxins from elapid and sea snake venoms. Taiwan yi xue hui za zhi J. Formosan Med. Assoc. 1972; 71: 344–349
   Google Scholar
• Li Y., Jiang H. L., Zhu K. J., Liu J. H., Hao Y. L. Preparation, Characterization and nasal delivery of α-cobrotoxin-loaded poly (lactic -co-glycolide)/polyanhydride microspheres. J. Control. Real 2005; 108: 10–20
   PubMed Web of Science ®Google Scholar
• Lindstrom J. The structure of neuronal nicotinic receptors. In: Neuronal Nicotinic Receptors. In:. Handbook of Experimental Pharmacology, F. Clementi, D. Fornassi, C. Gotti. Springer Verlag, Berlin 2000; Vol. 44: 101–162
   Google Scholar
• Lou X., Liu Q., Tu X., Wang J., Teng M, Niu L., Schuller D. J., Huang Q., Hao Q. The atomic resolution crystal structure of atrotoxin determined by single wavelength anomalous diffraction phasing. J. Biol. Chem. 2004; 279: 39094–39104
   PubMedGoogle Scholar
• Mao H., Hajduk P. J., Craig R., Bell R., Borre T., Fesik S. W. Rational design of diflunisal analogues with reduced affinity for human serum albumin. J. Am. Chem. Soc. 2001; 123: 10429–10435
   PubMed Web of Science ®Google Scholar
• Menez A., Servent D., Gasparini S. The binding sites of animal toxins involve two components a clue for selectivity, evolution and design of proteins?. Perspectives in Molecular Toxicology, A. Menez. John Willey & Sons, ChichesterEngland 2002; 175–200
   Google Scholar
• Neibig R. R., Cohen J. B. Equilibrium binding of 3H-tubecurarine and 3H-acetylcholine by Torpedo postsynaptic membranes: Stoichiometry and ligand binding interactions. Biochemistry 1979; 18: 5464–5475
   PubMedGoogle Scholar
• Phui Yee J. S., Gong N. L., Afifiyan F., Ma D. H., Lay P. S., Armugam A., Jeyaseelan K. Snake postsynaptic neurotoxins: gene structure, phylogeny and applications in research and therapy. Biochimie 2000; 86: 137–149
   Google Scholar
• Rees B., Bilwaes A. Three dimensional structures of neurotoxins and cardiotoxins. Chem. Res. Toxicol. 1993; 6: 385–406
   PubMedGoogle Scholar
• Rosenthal J. A., Levandoski M. M., Chang B., Potts J. F., Shi Q., -L., Hawort E. The functional role of positively charged amino acid side chains in α-bungarotoxin revealed by site-directed mutagenesis of a His-tagged recombinant α-bungarotoxin. Biochemistry 1999; 38: 7847–7855
   PubMedGoogle Scholar
• Ruan K. H., Stiles B. G., Atassi M. Z. The short neurotoxin binding regions on the chain of the human and Torpedo california acetylcholine receptor. Biochem. J. 1991; 274: 849–854
   PubMed Web of Science ®Google Scholar
• Samson A. O., Chill J. H., Rodriguez E., Scherf T., Anglister J. NMR mapping and secondary structure determination of the major acetylcholine receptor alpha-subunit determinant interacting with alpha-bungarotoxin. Biochemistry 2001; 40: 5464–5473
   PubMedGoogle Scholar
• Scherf T., Kasher R., Balass M., Fridkin M., Fuchs S., Katchalski-Katzir E. A beta-hairpin structure in a 13-mer peptide that binds alfa-bungarotoxin with high affinity and neutralizes toxicity. Proc. Natl. Acad. Sci. USA 2001; 98: 6629–6634
   PubMed Web of Science ®Google Scholar
• Servent D., Menez A. Snake neurotoxins that interact with nicotinic acetylcholine receptors. Handbook of Neurotoxicology, Vol 1, E. J. Massaro. Humana Press, TotowaNew Jersey 2001; 385–425
   Google Scholar
• Servent D., Winckler-Dietrich V., Hu H. Y., Kessler P., Drevent P., Bertrand D., Menez A. J. Biol. Chem. 1997; 272: 24279–24286
   PubMed Web of Science ®Google Scholar
• Sher E., Giovannini F., Boot J., Lang B. Peptide neurotoxins, small cell lung carcinoma and neurological paraneoplastic syndromes. Biochime 2000; 82: 927–936
   PubMedGoogle Scholar
• Sixma T. K., Smit A. B. The acetylcholine binding protein: A secreted glial protein that provides a high resolution model for the extracellular domain of pentameric ligand-gated ion channels. Ann. Rev. Biophy. Biomol. Struct. 2003; 32: 311–334
   PubMedGoogle Scholar
• Smit A. B., Syed N. I., Schaap D., Minnen J., Klumpermank J, Kits J. K., Lodder H., VanderSchors R. C., Elk R., Sorgedrager B., Brejc K., Sixma T. K., Geraerts W. P. G. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 2001; 411: 261–268
   PubMed Web of Science ®Google Scholar
• Spura A., Riel R. U., Freedman N. D., Agrawal S., Seto C., Hawrot E. Biotinylation of substituted cysteines in the nicotinic acetylcholine receptor reveals distinct binding modes for alpha-bungarotoxin and erabutoxin A. J. Biol. Chem. 2000; 275: 22452–22460
   PubMedGoogle Scholar
• Taylor P., Molles B., Malany S., Osaka H. Toxins as probes for structure and specificity of synaptic target proteins. Perspectives in Molecular Toxicology, A. Menez. John Willey & Sons, ChichesterEngland 2002; 271–280
   Google Scholar
• Teixeira-Clerc F., Menez A., Kessler P. How do short neurotoxins bind to muscular-type nicotinic acetylcholine receptor. J. Biol. Chem. 2002; 277: 124406–12417
   Google Scholar
• Vulfins C. A., Krasts I. V., Utkin Y. N., Tsetlin V. I. Nicotinic receptors in Lymnaea stagnalis neurons are blocked by alpha-neurotoxins from cobra venoms. Neurosci. Lett. 2001; 309: 189–192
   PubMedGoogle Scholar
• Wang H., Amella C. A., Tanovic M., Susaria S., Li J. H., Wang H., Jang H., Ulloa L., Al-Abed Y., Czura C. J., Tracey K. J. Nicotinic acetylcholine receptor 7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384–388
   PubMed Web of Science ®Google Scholar
• Xiong Y., Wang W. Using snake venom to substitute for addictive drugs. Toxicon 1992; 30: 567–568
   Google Scholar
• Yang C. C. Crystallization and properties of cobrotoxin from Formosan cobra venom. J. Biol. Chem. 1965; 240: 1616–1618
   PubMed Web of Science ®Google Scholar
• Yang C. C. The disulfide bonds of cobrotoxin and their relationship to lethality. Biochim. Biophys. Acta 1967; 133: 346–355
   PubMed Web of Science ®Google Scholar
• Yang C. C. Cobrotoxin interactions with Ach. In. Pharmacology., M. J. Rand, C. Raper. ElsevierBiomedical Division, Amsterdam 1987; 871
   Google Scholar
• Yang C. C. Cobrotoxins: structure and function. J. Nat. Toxins 1999; 8: 221–233
   PubMedGoogle Scholar
• Yang C. C., Yang H. J., Huang J. S. The amino acid sequence of cobrotoxin. Biochim. Biophys. Acta. 1969; 188: 65–77
   PubMed Web of Science ®Google Scholar
• Yang C. C., Yanf H. J., Chiu R. H. C. The position of disulfide bonds in cobrotoxin. Biochim. Biophys. Acta 1970; 214: 355–363
   PubMed Web of Science ®Google Scholar
• Yang C. C., Chang C. C., Liou I. F. Studies on the status of arginine residues in cobrotoxin. Biochim. BioPhys. Acta 1974; 365: 1–14
   PubMed Web of Science ®Google Scholar
• Yu C., Bhaskaran R., Chaung L. C., Yang C. C. Solution structure of cobrotoxin: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. Biochemistry 1993; 32: 2131–2136
   PubMed Web of Science ®Google Scholar
• Yu C., Lee C. S., Chaung L. C., Shei Y. R, Wang C. Y. Two dimensional NMR studies and secondary structure of cobrotoxin in aqueous solution. Eur. J. Biochem. 1990; 193: 789–799
   PubMedGoogle Scholar
• Yu. C., Bhaskaran R., Yang C. C. Structure in solution of toxins from Taiwan cobra venom, Naja naja atra, derived from NMR spectra. J. Toxicol. Toxin. Rev. 1994; 13: 291–315
   Web of Science ®Google Scholar
• Zinn-Justin S., Roumestand C., Gilquin B., Bontems F., Menez A., Toma F. Three dimensional solution structure of curaremimetic toxin from Naja nigricollis venom: a proton NMR and molecular modeling study. Biochemistry 1992; 31: 11335–11347
   PubMed Web of Science ®Google Scholar